McKesson Corporation is a leading healthcare services and information technology company that specializes in the distribution of pharmaceuticals and medical supplies. The company provides a comprehensive range of services that enhance the efficiency of healthcare systems, including drug distribution to pharmacies, hospitals, and other healthcare providers. Additionally, McKesson offers innovative solutions for managing medical costs, optimizing inventory, and improving patient care through data analytics and technology. By ensuring the timely delivery of critical medical products and services, McKesson plays a vital role in the healthcare ecosystem, supporting both providers and patients. Read More
Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
This week, from August 4th to August 10th, 2025, marks a busy period in the second-quarter earnings season, with hundreds of companies across various sectors scheduled to report their financial results. These earnings calls are crucial events for investors, analysts, and the broader market, as they provide insights into corporate
U.S. equities slipped midday Thursday as corporate earnings and fresh tariff announcements from President Donald Trump drove divergent moves in heavyweight names.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Healthcare distributor and services company McKesson (NYSE:MCK) announced better-than-expected revenue in Q2 CY2025, with sales up 23.4% year on year to $97.83 billion. Its non-GAAP profit of $8.26 per share was 1.4% above analysts’ consensus estimates.
McKesson Corporation (NYSE: MCK) has released its fiscal 2026 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Synergy CHC Corp. (NASDAQ: SNYR), the consumer health powerhouse behind the FOCUSfactor® brand, is making headlines again as its CEO took to the airwaves to spotlight the company’s 25-year journey from brain-boosting tablets to energy drinks and weight management innovation.
U.S. stocks rebounded sharply on Wednesday, fully erasing last Friday's losses, as upbeat corporate earnings and renewed investor optimism outweighed concerns over escalating trade tensions.
Healthcare distributor and services company McKesson (NYSE:MCK)
will be reporting results this Wednesday after market close. Here’s what investors should know.
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share in the prior quarter. The dividend will be payable on October 1, 2025, to stockholders of record on September 2, 2025.
McKesson Corp (MCK) shows strong growth fundamentals and a promising technical breakout setup, making it a potential growth stock pick with upside potential.
Growth is oxygen.
But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
MCKESSON CORP (NYSE:MCK) offers strong growth in healthcare distribution with reasonable valuation and solid financial health, making it a candidate for growth-at-a-price investors.
Synergy CHC Corp. (NASDAQ: SNYR) is capturing national attention with the announcement of a strategic distribution partnership with McKesson Canada, a division of McKesson Corporation (NYSE: MCK) . The agreement gives FOCUSfactor® direct access to thousands of pharmacies and health-focused retailers across Canada, igniting the next phase of its aggressive North American expansion.
MCKESSON CORP (NYSE:MCK) shows strong growth fundamentals and a bullish technical setup, making it a stock to watch. The company's solid financials and breakout potential suggest further upside.
